ALDVI: Advicenne S.A. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Advicenne S.A.

FRA:ALDVI

SummaryFactSheetFinancial
Price
€1.08
Loss Chance
50.9%
3.46JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Pharmaceuticals
9 / 10
Health Care
48 / 69
France
?
374 / 520
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
AB Science S.A.
FRA:AB
3.01
€0.87
100.00%
THX Pharma Société Anonyme
FRA:ALTHX
0.01
€3.29
100.00%
Boiron SA
FRA:BOI
4.77
€27.80
59.33%
Euroapi S.A.
FRA:EAPI
3.56
€1.22
66.20%
Ipsen S.A.
FRA:IPN
7.45
€157.20
24.88%
Jitta Factors
Growth Opportunity (62)
Recent Business Performance (72)
Financial Strength (27)
Return to Shareholders (15)
Competitive Advantage (56)
Jitta Signs
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.46
100.00%
4.47
61.49%
2.84
> 1,000%
Pharmaceuticals
3.01
100.00%
0.01
100.00%
4.77
59.33%
COMPANY DESCRIPTION
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
www.advicenne.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.